First, we analyzed the primary endometrial adenocarcinoma (EMCA) cohort (n = 248) of the Cancer Genome Atlas Project (TCGA) study [18], in which CCND1 was mutated in 6.1% (15 of 248) cases (Table 1). The gene discussed is CCND1; the disease is cancer.